Stop Pills That Kill Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Requires the DEA to create a plan and the Justice Department to submit annual reports focused on counterfeit fentanyl or methamphetamine substances, especially counterfeit pills.
Who Benefits and How
Law-enforcement and public-health officials could gain more structured planning and data on counterfeit pill threats.
Who Bears the Burden and How
DEA, DOJ, and ONDCP would have to prepare the operational plan and recurring reports and collect the supporting data.
Key Provisions
- Requires a DEA operation and response plan focused on counterfeit fentanyl and methamphetamine substances.
- Requires annual congressional reporting on seizures, charges, convictions, and prevention measures related to those substances.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Requires the DEA to create a plan and the Justice Department to submit annual reports focused on counterfeit fentanyl or methamphetamine substances, especially counterfeit pills.
Key Policy Areas
Criminal Justice, Healthcare
Primary Purpose
Requires the DEA to create a plan and the Justice Department to submit annual reports focused on counterfeit fentanyl or methamphetamine substances, especially counterfeit pills.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Public-health and law-enforcement stakeholders confronting counterfeit pill threats
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- DEA, DOJ, and ONDCP officials preparing the required plans and reports
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Grassley (for himself and Ms. Hassan) introduced the following …
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
DEA officials designing and implementing the required counterfeit-pill response plan, DOJ, DEA, and ONDCP officials compiling the recurring counterfeit-pill reports
Public-health and law-enforcement efforts aimed at counterfeit pill trafficking
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology